Dialysis And Sleep: Safe Pills For Patients

can dialysis patients take sleeping pills

Sleep disorders are common in dialysis patients, with nearly half of those undergoing long-term hemodialysis suffering from chronic insomnia. While some studies have found that sleeping pills can increase the risk of chronic kidney disease, others have shown that certain types of benzodiazepines are prescribed in dialysis populations for sleep disorders. The use of sleeping pills in dialysis patients is a complex issue, as the relationship between the two is not yet fully understood. Additionally, the average dialysis patient takes 13 medications, which can contribute to insomnia. As a result, it is crucial for dialysis patients to consult their doctors before taking any sleeping pills or natural remedies to ensure their safety and explore alternative treatments.

Characteristics Values
Sleep disorders in dialysis patients Very common
Reasons for sleep disorders Side effects or interactions of multiple medications, sleep apnea, restless legs, and circadian rhythm disorder
Average number of medications taken by dialysis patients 13 medications or at least 19 pills a day
Common sleeping pills taken by dialysis patients Benzodiazepines such as temazepam, lorazepam, alprazolam, and clonazepam
Alternative treatments for insomnia CBT-I, antidepressants like trazodone, and off-label drugs
Effectiveness of alternative treatments CBT-I and trazodone have shown little effectiveness in treating insomnia in dialysis patients
Risks associated with trazodone Higher cardiovascular risk
Non-pharmacological treatments for insomnia Cognitive-behavioral psychotherapy, establishing a fixed sleep schedule, creating a friendly sleeping environment, etc.

shunsleep

Dialysis patients are prone to insomnia, sleep apnea, restless leg syndrome, and circadian rhythm disorder

Dialysis patients are at an increased risk of developing sleep disorders. Sleep disorders are common in patients with chronic renal failure, and the condition is not improved by conventional hemodialysis or peritoneal dialysis. Sleep apnea, insomnia, restless leg syndrome, and circadian rhythm disorders are some of the sleep issues that dialysis patients face.

Insomnia is prevalent among patients on maintenance haemodialysis, and the COVID pandemic may have exacerbated the problem. The efficacy of insomnia interventions for these patients is unclear due to limited data. However, it is essential to address this issue and increase access to treatments.

Restless leg syndrome (RLS) is also more common in dialysis patients with end-stage renal disease (ESRD) than in the general population. RLS is often overlooked in dialysis centers, but it can significantly impair patients' quality of life. The prevalence of RLS in ESRD patients undergoing dialysis ranges from 6.6% to 70%, much higher than the 3 to 9% prevalence in the general population.

Sleep apnea is another common issue for dialysis patients with chronic renal failure. Nocturnal hemodialysis, performed at home while the patient sleeps, has been found to improve sleep apnea in these patients. This form of dialysis provides better clearance of small molecules, improved control of serum phosphate concentrations, and hemodynamic stability.

Circadian rhythm disorders are also associated with dialysis patients, particularly older men with nocturia. Altered circadian rhythms can lead to sleep disturbances, depression, arterial hypertension, and increased mortality and morbidity. While the mechanisms behind these disruptions are not fully understood, interventions such as timed light therapy and early time-restricted feeding have shown promising results in improving nighttime blood pressure and insulin sensitivity.

shunsleep

Benzodiazepines are prescribed to dialysis patients for anxiety, sleep disorders, restless leg syndrome, and depression

Benzodiazepines are a category of medications that act on benzodiazepine receptors in the central nervous system (CNS). They are commonly prescribed to treat a range of conditions, including anxiety, sleep disorders, and seizures. Benzodiazepines can be useful in treating insomnia and related sleep disorders, and they are often prescribed for this purpose.

In the context of dialysis patients, studies have found that benzodiazepines such as temazepam, lorazepam, alprazolam, and clonazepam have been prescribed to address various issues. These issues include anxiety, sleep disorders, restless leg syndrome, and depression. The use of benzodiazepines in this population is notable, as studies have indicated a potential association between benzodiazepine use and increased mortality rates. However, the underlying mechanisms for this association are not yet fully understood.

It is important to note that the use of benzodiazepines may carry risks, including the potential for misuse, habit formation, and overdose. Additionally, in older adults, benzodiazepines may lead to cognitive impairment, falls, and fractures. As such, the benefits and risks of benzodiazepine use should be carefully considered, especially in the context of dialysis patients who may have multiple factors contributing to their sleep disturbances.

While insomnia is prevalent among dialysis patients, studies have shown that commonly used treatments, such as cognitive behavioral therapy and certain antidepressants, have not been effective in improving sleep quality for this specific population. This highlights the complexity of managing sleep disorders in dialysis patients and the need for further research to identify safe and effective interventions.

In summary, benzodiazepines are prescribed to dialysis patients for anxiety, sleep disorders, restless leg syndrome, and depression. However, the potential benefits must be carefully weighed against the risks associated with benzodiazepine use, and further research is needed to fully understand the impact of these medications on this vulnerable population.

shunsleep

Cognitive behavioural therapy and trazodone have proven ineffective in treating insomnia in dialysis patients

Sleep disorders are common among patients with chronic kidney disease (CKD) and those receiving dialysis. Nearly half of people undergoing long-term dialysis due to end-stage kidney disease also suffer from chronic insomnia, severely impacting their quality of life.

A study conducted at 26 dialysis centres in Albuquerque and Seattle starting in 2018 found that two commonly used treatments for insomnia—cognitive behavioural therapy for insomnia (CBT-I) and the antidepressant drug trazodone—were ineffective in improving sleep among dialysis patients.

CBT-I is a standardized intervention that helps people restructure inaccurate or unhelpful beliefs about sleep and promotes relaxation and healthy sleep habits. Despite being the standard treatment for insomnia in adults, it did not yield meaningful results for dialysis patients in the study.

Trazodone, an older antidepressant, is often prescribed off-label for insomnia due to its sedative effects. However, the study found that it did not improve insomnia symptoms in dialysis patients. Additionally, trazodone was associated with a higher risk of serious cardiac complications in this patient population.

There are several possible explanations for the failure of these treatments among dialysis patients. One theory is that dialysis itself may be a contributing factor to insomnia. Another factor is that dialysis patients often have multiple serious medical conditions, such as sleep apnea, restless legs, and circadian rhythm disorders, which can disrupt sleep. Furthermore, the side effects and interactions of the numerous medications taken by dialysis patients may also contribute to insomnia.

shunsleep

Dialysis patients should avoid over-the-counter remedies and consult doctors for non-pharmacological treatments

Sleep disorders are common in dialysis patients, and the use of sleeping pills is prevalent. However, the relationship between sleeping pill use and the subsequent risk of chronic kidney disease and end-stage renal disease is not yet fully understood. While some studies have found an association between sleeping pill use and CKD risk, the mechanisms underlying this association are unclear. Benzodiazepines, such as temazepam, lorazepam, alprazolam, and clonazepam, have been prescribed in dialysis populations for sleep disorders, but sedative use has been linked to increased mortality.

Dialysis patients should be cautious about taking over-the-counter remedies, as these may have unknown interactions with their existing medications. It is important for dialysis patients to consult their doctors and seek non-pharmacological treatments for sleep disorders. Cognitive-behavioral psychotherapy has been indicated as the most effective form of non-pharmacological treatment for insomnia. Psychologists can assess sleep quality and propose tailored intervention plans, addressing issues such as sleep apnea, excessive daytime sleepiness, and restless leg syndrome, which are common in dialysis patients.

Additionally, patients can implement behavioural techniques for better sleep hygiene, such as establishing a fixed sleep schedule, maintaining a quiet and dark sleeping environment, avoiding stimulating activities before bed, and reducing stress through laughter and aromatherapy. These practices can help improve sleep quality without the need for over-the-counter remedies.

While commonly used insomnia treatments like cognitive behavioural therapy and antidepressants have shown limited effectiveness in dialysis patients, it is still crucial for patients to consult their doctors. Doctors can help assess the risk-benefit ratio of treatments and make careful prescribing decisions. Furthermore, dialysis patients often have multiple reasons for disturbed sleep, including side effects from various medications and underlying comorbidities. Therefore, seeking professional advice is essential to address the specific needs and complexities of each patient.

shunsleep

Sleep hygiene practices like a fixed sleep schedule, a comfortable environment, and reduced screen time can aid sleep

Sleep disorders are common among dialysis patients, and the use of sleeping pills may be associated with an increased risk of chronic kidney disease (CKD) and end-stage renal disease (ESRD). While dialysis patients may be prescribed benzodiazepines for sleep disorders, it's important to explore alternative solutions first, such as sleep hygiene practices.

Sleep hygiene is a collection of practices and routines that promote better sleep quality. One such practice is maintaining a fixed sleep schedule. This involves going to bed and waking up at the same time every day, including weekends. While consistency is important, the National Sleep Foundation suggests that after a week of insufficient sleep, it's beneficial to catch up on sleep during the weekends. The recommended sleep duration for adults is seven to nine hours per night, but this can vary depending on age and individual health circumstances.

Creating a comfortable environment is another crucial aspect of sleep hygiene. This includes minimizing disruptions, reducing noise and light, and maintaining a cool temperature in the bedroom. Heavy curtains, rugs, and light-blocking shades can help create a quiet and dark space. Keeping the room slightly cool, around 65°F to 70°F, is ideal for most people. Ensuring your mattress and pillows are comfortable and replacing them when worn out is also essential.

Reducing screen time is a significant component of improving sleep hygiene. The use of electronic devices before bed can interfere with sleep due to the light exposure and stimulating content. It's recommended to put away electronic devices at least 30 minutes before bedtime and opt for calming music, guided relaxation, or reading for pleasure instead. Establishing a relaxing bedtime routine that includes activities like taking a warm bath, stretching, or deep breathing can also aid in promoting better sleep.

Frequently asked questions

While there is no definitive answer to this question, studies have shown that common insomnia treatments such as CBT-I (cognitive-behavioral therapy for insomnia) and trazodone, an antidepressant with sedative effects, have not been effective in treating insomnia in dialysis patients. Benzodiazepines, a type of sleeping pill, have been prescribed to dialysis patients in the past, but their use has been associated with an increased risk of mortality and other negative side effects.

There are several alternatives to sleeping pills that dialysis patients can try to improve their sleep quality. These include establishing a fixed sleep schedule, creating a comfortable and peaceful sleeping environment, and engaging in relaxing activities before bed, such as reading a book or taking a hot shower.

Sleeping pills may pose certain risks for dialysis patients. For example, they may negatively interact with the multiple medications that dialysis patients are often already taking, leading to unintended side effects. Additionally, there is a potential risk of higher cardiovascular risk with certain sleeping pills, such as trazodone.

Treating insomnia in dialysis patients can be challenging due to the multiple factors that may contribute to their sleep disturbances. These can include sleep apnea, restless leg syndrome, circadian rhythm disorders, and the side effects of medications for other ailments. As such, it is important for dialysis patients to consult with their doctors and psychologists to determine the best treatment approach for their specific needs.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment